all News
February 2020
-
10 Feb 2020New research has deciphered how rogue communications in blood stem cells can cause Leukaemia. The discovery, published in the journal Science, could pave the way for new, targeted medical treatments that block this process. Blood cancers like leukaemia occur when mutations in stem cells cause them to produce too many blood cells.
-
03 Feb 2020University of Dundee researchers have shown how a natural product derived from a group of fungi that has inspired horror novels, movies and computer games works to switch on a protein known to affect cancer cells.
January 2020
-
30 Jan 2020Dr. Henry McSorley has joined the School this month as a member of the Division on Cell Signalling and Immunology. He will be joint deputy head of division alongside Hari Hundal.
-
14 Jan 2020Researchers in the Moraga group report the engineering of new tools to manipulate the immune response with the potential to treat human disorders. The research was done in collaboration with the Kazemian group (Purdue University, USA) and Mitra group (Centre de Recherche Jean-Pierre Aubert, France). The research was published in the journal eLife.
December 2019
-
04 Dec 2019The School has welcomed three new group leaders in recent months. They are currently establishing their laboratories across three of our divisions. Leeanne McGurk has joined the Division of Cell and Developmental Biology, Megan Bergkessel has joined the Division of Molecular Microbiology while Gabriel Sollberger has joined the Division of Cell Signalling and Immunology. Leeanne McGurk Leeanne joins the School from the University of Pennsylvania, Philadelphia where she was a postdoctoral research associate in the laboratory of Nancy Bonini.
November 2019
-
06 Nov 2019Paul Crocker is stepping down as Head of Cell Signalling and Immunology (CSI) after 5 years in the position. While reflecting on his time in this role, Paul wanted to acknowledge the key people that made his job so much easier.
October 2019
-
07 Oct 2019Scientists at the University of Dundee have carried out one of the most comprehensive studies into how immune cells sense and respond to their environment to fight infection and destroy tumours. The research team, who have published their findings in the journal Nature Immunology, said the results provide important insights into how immune responses might be manipulated for the treatment of autoimmune diseases and cancer.
July 2019
-
10 Jul 2019Prof. Grahame Hardie and two of his co-workers, Diana Vara-Ciruelos and Fiona Russell, have published a review in the journal Open Biology with a title inspired by the classic novella by the Scottish author Robert Louis Stevenson. Their article discusses the controversial role in cancer of AMP-activated protein kinase (AMPK), which was first defined and named by Prof. Hardie at the University of Dundee in the late 1980s.
May 2019
-
12 May 2019Professor Hari Hundal and Dr Sarah McKim were named winners in their respective categories in the Dundee University Student Association (DUSA) Student-led Teaching Awards on Friday night. Hari jointly won in the Most Inspirational Teaching category while Sarah won the Best Postgraduate Supervisor category. The shortlisted nominees (from over 300 nominations) and the students who nominated attended the Student Led Teaching Awards Dinner last Friday, where the winners were announced.
April 2019
-
17 Apr 2019Researchers from the Division of Cell Signalling and Immunology in the School have shown that a drug previously used to treat Type 2 diabetes could potentially be used to protect against cancer. A study carried out by Professors Grahame Hardie and Doreen Cantrell has shown that the drug phenformin protects mice against a type of cancer called T-cell lymphoma. It does this by switching on the protein AMPK, which was first defined by Professor Hardie in the 1980s. Subsequent research at Dundee showed a link between AMPK and cancer.
